Health Condition 1: N739- Female pelvic inflammatory disease, unspecified
Conditions
Interventions
Intervention1: Individualized Homoeopathic Medicines: According to symptoms similarity 200ch or 1M 1dose or 2 dose 4 globules for 14 days according to patients susceptibility
Control Intervention1: In
thin, yellowish white after menses.
2.Pain in ovarian region. 3.Bearing-down pains: in pelvic region,with uneasiness.
4.Menstrual pain.
5.Menses began ten days early (always regular before)
6.pain in
Sponsors
Dr MPK Homoeopathic Medical College Hospital and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1. Previously diagnosed cases of PID seeking homoeopathic treatment or newly diagnosed. 2. As per sign & symptoms and CDC (adopted from DC Duttaâ??s textbook of gynecology 7th edition) Patients with 3-4 confirmatory sign and symptoms given below shall be enrolled for the study irrespective of the diagnosis based on investigations- a. Pelvic pain or lower abdomen pain or back pain. b. Abnormal & heavy Vaginal discharge (purulent and or copious) c. Offensive vaginal odor. d. Cervical motion tenderness. e. Lower abdomen tenderness. f. Adnexal tenderness. g. Pruritis vulva. h. Burning. i. Dyspareunia. j. Irregular vaginal bleeding. k. Fever Diagnostic criteria- 1.symptoms as mentioned above. 2.USG/ laboratory investigation done if required in case of unclear symptoms given above.
Exclusion criteria
Exclusion criteria: 1. Cases which required any emergency treatment. 2. Patient pursuing other treatment and were not willing to leave it. 3. Pregnant women and lactating mothers will not be included in the study. 4.Immunocompromised patient such as suffering from HIV, Hepatitis B/C etc. 5.Cases with multi systemic illness will be excluded from the study and cases with advance pathology & malignancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in VAS score will be noted for every symptom before, during and after treatment and shall be analysed to assess the efficacy of treatment given.Timepoint: Changes in VAS score will be noted for every symptom before, during and after treatment and shall be analysed to assess the efficacy of treatment given at 12 month. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in WHO QOL-BREF scale will be noted for before and after treatment and shall be analysed to assess the efficacy of treatment given .Timepoint: 1year | — |
Countries
India
Contacts
Public ContactDr Ankita Srivastava
Dr MPK Homoeopathic Medical College Hospital And Research Centre Homoeopathy University
Outcome results
None listed